EAM
REVBW icon

Exos Asset Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Exos Asset Management’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,000
Closed -$12K – 654
2021
Q2 		$12K Hold
19,000
– – 0.01% 752
2021
Q1 		$10K Buy
+19,000
New +$17.8K 0.01% 375

Other funds holding REVBW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Exos Asset Management's REVBW Position: Q3 2021 in Review

Exos Asset Management sold out of Revelation Biosciences Warrant (REVBW) in Q3 2021, closing a stake of 19,000 shares — an estimated $12K sold.

Exos Asset Management first reported a position in REVBW in Q1 2021 and held it in 2 quarters. The position peaked at $12K in Q2 2021. 18 funds tracked by Wall St. Rank hold REVBW as of Q3 2021.

  • Exos Asset Management reported no remaining Revelation Biosciences Warrant position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 19,000 Revelation Biosciences Warrant shares in Q3 2021, an estimated $12K.
  • Exos Asset Management first reported a position in Revelation Biosciences Warrant in Q1 2021 and held it in 2 quarters.
  • Exos Asset Management's Revelation Biosciences Warrant position peaked at $12K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.